138.81
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $138.81, with a volume of 3.38M.
It is up +11.27% in the last 24 hours and up +31.69% over the past month.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
See More
Previous Close:
$124.75
Open:
$136
24h Volume:
3.38M
Relative Volume:
3.57
Market Cap:
$6.14B
Revenue:
$2.96B
Net Income/Loss:
$-194.74M
P/E Ratio:
-6.7524
EPS:
-20.557
Net Cash Flow:
$245.44M
1W Performance:
+9.87%
1M Performance:
+31.69%
6M Performance:
+4.54%
1Y Performance:
+5.61%
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TFX
Teleflex Incorporated
|
138.81 | 5.52B | 2.96B | -194.74M | 245.44M | -20.56 |
|
ISRG
Intuitive Surgical Inc
|
483.62 | 160.28B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
155.65 | 44.57B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
47.16 | 38.56B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ALC
Alcon Inc
|
76.43 | 37.93B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
222.04 | 32.23B | 5.40B | 1.49B | 1.78B | 10.12 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Upgrade | BofA Securities | Underperform → Neutral |
| Mar-27-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-27-26 | Upgrade | Needham | Hold → Buy |
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
TFX (Teleflex Incorporated) records 17.2 percent year over year revenue growth despite Q4 2025 EPS miss, shares edge higher.Outperform - Cổng thông tin điện tử tỉnh Lào Cai
Teleflex stock hits 52-week high at 138.95 USD By Investing.com - Investing.com South Africa
Teleflex gains on report PE firms teamed up for takeover offer (update) (TFX:NYSE) - Seeking Alpha
Teleflex jumps on fresh take-private bid chatter involving CVC and GTCR - Quiver Quantitative
This Is Why Teleflex Stock (TFX) Rallied Today - TipRanks
Ruffer LLP Acquires Shares of 42,166 Teleflex Incorporated $TFX - MarketBeat
Teleflex Stock Surges Over 8% In Pre-Market Trading: Here's Why - Benzinga
CVC Capital, GTCR bid to take medical device maker Teleflex private, source says - KELO-AM
A Look At Teleflex (TFX) Valuation As New Board Chairman Andrew Krakauer Takes The Helm - simplywall.st
Teleflex (TFX) Potentially Targeted for Acquisition by CVC and G - GuruFocus
CVC, GTCR Weigh Take-Private of Medical Equipment Provider Teleflex - Bloomberg.com
A Look at Teleflex Inc (TFX) After 5.5% Decline -- GF Value $183 - GuruFocus
CVC, GTCR weigh takeover of medical device maker Teleflex, sources say - TradingView
CVC, GTCR weigh taking Teleflex private, Bloomberg News reports - marketscreener.com
CVC, GTCR weigh take-private of medical equipment provider TeleflexBloomberg news - marketscreener.com
Teleflex Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cwm LLC Reduces Position in Teleflex Incorporated $TFX - MarketBeat
Teleflex Incorporated (TFX) Stock Technical Support (In Focus) 2026-04-20Crowd Risk Alerts - Cổng thông tin điện tử Tỉnh Sơn La
Waterfront Wealth Inc. Acquires Shares of 16,799 Teleflex Incorporated $TFX - MarketBeat
Teleflex Incorporated (TFX) Stock Analysis: A Healthcare Player With Steady Prospects - DirectorsTalk Interviews
Teleflex Inc. stock (US8793691069): Is its medtech innovation edge strong enough for steady growth? - AD HOC NEWS
Teleflex Nominates Director, Plans Share Buybacks and Board Changes - MyChesCo
Teleflex Inc stock (US8793691069): Why Google Discover changes matter more now - AD HOC NEWS
Teleflex Inc stock (US8793691069): Why its medical device leadership matters more now for investors - AD HOC NEWS
Teleflex Inc. stock rises Friday, still underperforms market - MarketWatch
Teleflex Incorporated : 2025 ANNUAL REPORT (2025 Teleflex Annual Report) - marketscreener.com
Teleflex Incorporated : 2026 PROXY STATEMENT (2026 Teleflex Proxy Statement) - marketscreener.com
Teleflex Incorporated Investigated by the Portnoy Law Firm - GlobeNewswire
Robeco Institutional Asset Management B.V. Has $3.15 Million Stock Holdings in Teleflex Incorporated $TFX - MarketBeat
Teleflex Features ARROW® JACC with Chlorag+ard® Technology, the Only Long-Term Antimicrobial and Ant - Yahoo
Teleflex (TFX) Earnings Date and Reports 2026 $TFX - MarketBeat
Teleflex Inc (TFX) Stock Up 3.1% and Still Undervalued -- GF Sco - GuruFocus
Teleflex Inc (TFX) Stock Up 3.1% and Still Undervalued -- GF Score: 70/100 - GuruFocus
Vascular Closure Devices Market Set for Steady Growth at 5.70% CAGR Through 2032: DelveInsight | Abbott, Teleflex, and Medtronic - Barchart.com
Deals tracker: CPIhealth expands Indiana footprint - Modern Healthcare
RBC Raises Price Target on Teleflex to $135 From $125, Keeps Sector Perform Rating - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Cigna (CI) and BioNTech SE (BNTX) - The Globe and Mail
Teleflex Incorporated (NYSE:TFX) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Teleflex (TFX) VP Reterski details stock, options and RSUs in Form 3 - Stock Titan
TELEFLEX INC ($TFX) Former President and CEO 2025 Pay Revealed - Quiver Quantitative
Teleflex says Irenic falsely claimed company was not open for buyout offers - MSN
Teleflex (NYSE: TFX) outlines board changes, CEO transition and $1.8B divestiture plan - Stock Titan
Teleflex Developments Draw Market Attention in Healthcare Space - Kalkine Media
Bank of America Upgrades Teleflex to Neutral - National Today
Teleflex (NYSE:TFX) Upgraded to Neutral at Bank of America - MarketBeat
BofA upgrades Teleflex stock rating on portfolio changes - Investing.com UK
BofA upgrades Teleflex stock rating on portfolio changes By Investing.com - Investing.com South Africa
Teleflex Inc. stock (US8793691069): Is vascular access strength enough to drive medtech upside now? - AD HOC NEWS
Is Teleflex’s Governance Overhaul And Capital Moves Altering The Investment Case For TFX? - Sahm
Teleflex Stock Crosses 200-Day Moving Average - National Today
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Teleflex Incorporated Stock (TFX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Krakauer Andrew A | Director |
Aug 05 '25 |
Buy |
115.25 |
1,000 |
115,250 |
7,192 |
| Kelly Liam | Chairman, President & CEO |
Aug 05 '25 |
Buy |
115.07 |
1,500 |
172,605 |
45,267 |
| Ryu Jaewon | Director |
Aug 05 '25 |
Buy |
115.00 |
1,500 |
172,500 |
3,727 |
| HAGGERTY GRETCHEN R | Director |
Aug 06 '25 |
Buy |
114.75 |
500 |
57,375 |
6,305 |
| Duncan Candace H | Director |
May 05 '25 |
Option Exercise |
123.04 |
4,833 |
594,652 |
9,561 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):